|
|
|
|
|
| What Everyone Needs To Know About Polymorphs | Q&A | Curia | Build a strong foundation in solid form science — especially polymorphism — to reduce risk, control variability, and accelerate your path from development to reliable, cost-effective manufacturing. |
|
|
| Complex Molecules, Complex Problems | Article | By Charles Johnson, Lonza | The support of an experienced CDMO is critical to overcoming complexity when working with highly potent APIs and when solving solubility challenges. |
|
|
|
|
|
By Louis Garguilo, Chief Editor, Outsourced Pharma | A lower-court ruling does not make a victory. But it adds a little sanity to this melodrama. On August 7, a U.S. District Judge did something that has been surprisingly rare in the long-running WuXi AppTec/BIOSECURE Act saga: He looked at the U.S. government's case for labeling WuXi a “Chinese military company” and decided the government had not shown enough evidence. Analysis from Chief Editor Louis Garguilo. | |
|
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
|
| Safely Scaling High Potency API Manufacturing | White Paper | Recipharm | Scaling HPAPI production demands disciplined containment and exposure control. Integrated operating models help manage risk while enabling compliant, reliable scale‑up. |
|
|
|
|
| Navigating Downstream Processing (DSP) | Article | Curia | DSP failures kill commercialization timelines. Learn how integrated harvest, filtration, and purification infrastructure protects product stability at scale. |
|
|
| Operational Readiness Frameworks For Pharma And Biotech | Article | By Paige Kane, Ph.D., CAI | Achieving top performance in life sciences requires a continuous journey from Operational Readiness (OR) to sustained Operational Excellence (OE), ensuring safe startup and long-term efficiency. |
|
|
|
|
|
|
|
OUTSOURCED PHARMA CAPABILITIES UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capabilities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
| Connect With Outsourced Pharma: |
|
|
|
